Chaoju Eye Care Holdings Limited (HKG:2219)

Market Cap	1.96B
Revenue (ttm)	1.50B
Net Income (ttm)	207.59M
Shares Out	690.76M
EPS (ttm)	0.30
PE Ratio	9.53
Forward PE	6.19
Dividend	0.24 (8.40%)
Ex-Dividend Date	Jun 10, 2025

Volume	953,500
Average Volume	591,692
Open	2.840
Previous Close	2.840
Day's Range	2.780 - 2.840
52-Week Range	2.400 - 3.710
Beta	0.52
RSI	57.33
Earnings Date	May 29, 2025

About Chaoju Eye Care Holdings

Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, myopia prevention and control, dry eye syndrome, and oculoplastic, as well as optical products and services. The company also provides treatment for eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye di...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1988
• Employees: 2,608
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2219

Financial Performance

In 2024, Chaoju Eye Care Holdings's revenue was 1.41 billion, an increase of 2.62% compared to the previous year's 1.37 billion. Earnings were 195.08 million, a decrease of -14.78%.

Financial numbers in CNY